Please assess the completion status of the following clinical trial:

Trial Title: Adhear Bone Conduction System

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~Aims 1 and 2:~* Adult English speaking patients who are experienced users of Bone Anchored Implants (BAIs) for the indication of either single sided deafness or conductive hearing loss.~* Experienced will be defined as greater than 6 months of device use and no intermittent function of the device within 2 weeks of enrollment.~* Subjects will be limited to those who have normal hearing by bone conduction defined as a pure tone average of 25 dBHL or better at 500, 1000, 2000, \& 3000 Hz in at least one ear.~Aim 3:~* English speaking children 5 to 17 years of age and their primary guardian who present to the clinic for treatment by BAI on a headband device for the indications of single sided deafness or conductive hearing loss.~* Subjects will be limited to those who have no prior use of a BAI or bone conduction hearing device, normal hearing by bone conduction defined as a pure tone average of 25 dBHL or better at 500, 1000, 2000, \& 3000 Hz in at least one ear. For those children where this cannot be definitively established, children will be included who display clinical signs of normal bone conduction hearing beyond a reasonable doubt and may include such evidence as (but not limited to): auditory brainstem response, speech awareness thresholds, visual reinforcement audiometry, conditioning play audiometry, CT scans, etc.)~Aim 3 a \& b:~* Pediatric bilateral or unilateral conductive hearing loss patients who are between the ages of 2 and 17 years of age~* Pediatric participants who are currently managed by the University of Miami with a bone conduction device attached to a softband.~Exclusion Criteria:~Aims 1 \& 2:~* Non-English speakers~* Participants reporting allergies to adhesives or highly reactive skin.~Aim 3:~* Pediatric participants who are non-English speakers.~* Children who have previous experience with a BAI or bone conduction hearing device will not be included for study.~* Pediatric participants reporting allergies to adhesives or highly reactive skin.~Aims 3a \& 3b:~* Pediatric participants who are non-English speakers.~* Pediatric participants reporting allergies to adhesives or highly reactive skin.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single-Sided Deafness Adult (Aim1) Group (Type: EXPERIMENTAL): Adult participants with single-sided deafness and are experienced bone conduction device users (6 months minimum of bone conduction device use and no intermittent use within the last 2 weeks) with an abutment implant will be provided with the Adhear system for 2 weeks (plus up to 90 days).
- Conductive Hearing Loss Adult (Aim 2) Group (Type: EXPERIMENTAL): Adult participants with conductive hearing loss and are experienced bone conduction device users (6 months minimum of bone conduction device use and no intermittent use within the last 2 weeks) with an abutment implant will be provided with the Adhear system for 2 weeks (plus up to 90 days).
- Adhear followed by BAHA (Aim 3) Group (Type: EXPERIMENTAL): Pediatric participants (aged 5-17 years) and their parents with conductive hearing loss or single-sided deafness who have not previously used a bone conduction device, will be provided with the Adhear system for 3 weeks (plus up to 90 days) followed by bone anchored hearing aid (BAHA) for another 3 weeks (plus up to 90 days).
- BAHA followed by Adhear (Aim 3) Group (Type: EXPERIMENTAL): Pediatric participants (aged 5-17 years) and their parents with conductive hearing loss or single-sided deafness who have not previously used a bone conduction device, will be provided with the BAHA system for 3 weeks (plus up to 90 days) followed by Adhear for another 3 weeks (plus up to 90 days).
- Pediatric Unilateral Conductive Hearing Loss (Aim 3a) Group (Type: EXPERIMENTAL): Pediatric participants (aged 2-17 years) and their parents with unilateral conductive hearing loss and are experienced bone conduction device users (6 months minimum of bone conduction device use) on a headband will be provided with the Adhear system for 2 weeks (plus up to 90 days).
- Pediatric Bilateral Conductive Hearing Loss (Aim 3b) Group (Type: EXPERIMENTAL): Pediatric participants (aged 2-17 years) and their parents with bilateral conductive hearing loss and are experienced bone conduction device users (6 months minimum of bone conduction device use) on a headband will be provided with the Adhear system. Participants who are fitted bilaterally will receive 2 Adhear systems (one for each ear) for 2 weeks (plus up to 90 days) at Visit 1. Participants who are fitted unilaterally will receive 1 Adhear system for 2 weeks (plus up to 90 days) at Visit 1, afterwards, will be fitted bilaterally at Visit 2 and receive the Adhear system for both ears for another 2 weeks (plus up to 90 days) for a total of 4 weeks (plus up to 180 days).

Based on this trial design, predict the completion outcome and termination type (if applicable).